triiodothyronine has been researched along with Carcinoma, Epidermoid in 13 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Excerpt | Relevance | Reference |
---|---|---|
"Thyroid function was measured by means of thyroid stimulating hormone (TSH), free thyroxine (FT4) and free triiodthyronine (FT3) in 43 patients who had nonthyroid head-neck carcinomas treated by radiotherapy or radiotherapy in combination with other modalities." | 3.80 | Hypothyroidism after radiotherapy of head and neck cancer. ( Bernát, L; Hrušák, D, 2014) |
"Hypothyroidism is recognized as a common complication of treatment in patients with head and neck carcinoma (HNC) and is reported in up to 75% of patients who receive combined treatment." | 1.31 | Pretreatment prevalence of hypothyroidism in patients with head and neck carcinoma. ( Bedrin, L; Dori, S; Horowitz, Z; Kronenberg, J; Mini, S; Peleg, M; Shoshani, Y; Taicher, S; Talmi, YP; Wolf, M, 2001) |
"The uterine cervical cancer cell line (CaSki) was cultured in vitro in the absence or presence of 17 beta-estradiol (E2) or L-triiodothyronine (T3) in a serum free condition." | 1.29 | [Effects of estrogen and thyroid hormone on EGF receptor expression, proliferative activity and SCC production in the CaSki cervical carcinoma cells]. ( Maruo, T; Matsuo, H; Mochizuki, M; Yoshida, S, 1995) |
"Triiodothyronine (T3) was directly correlated in the cancer patients with non-oxidative glucose utilization at the two physiological insulin concentrations (r = 0." | 1.29 | Reduced non-oxidative glucose utilization in cancer patients is associated with a low triiodothyronine concentration. ( Tayek, JA, 1995) |
"Eleven patients with head and neck cancer (ten men, one woman; mean age, 65 years) (larynx, six; oropharynx, two; tongue, one; skin, one; thyroid, one) with regional lymph node enlargements either in contiguity or firmly adherent to the vascular structures of the neck have been treated by means of external microwaves (915, 434 MHz) applicators." | 1.28 | Serum thyroid hormone changes in head and neck cancer patients treated with microwave hyperthermia on lymph node metastasis. ( Airoldi, M; Brossa, PC; D'Alberto, M; Gabriele, P; Pedani, F; Ragona, R; Tseroni, V, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (53.85) | 18.7374 |
1990's | 3 (23.08) | 18.2507 |
2000's | 1 (7.69) | 29.6817 |
2010's | 2 (15.38) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernát, L | 1 |
Hrušák, D | 1 |
Barbetakis, N | 1 |
Asteriou, C | 1 |
Tsilikas, C | 1 |
Izotova, IA | 1 |
Firsova, PP | 1 |
Matveenko, EG | 1 |
Kawaoi, A | 1 |
Okano, T | 1 |
Nemoto, N | 1 |
Shiina, Y | 1 |
Shikata, T | 1 |
Yoshida, S | 1 |
Maruo, T | 1 |
Matsuo, H | 1 |
Mochizuki, M | 1 |
Tayek, JA | 1 |
Mini, S | 1 |
Dori, S | 1 |
Horowitz, Z | 1 |
Bedrin, L | 1 |
Peleg, M | 1 |
Wolf, M | 1 |
Shoshani, Y | 1 |
Taicher, S | 1 |
Kronenberg, J | 1 |
Talmi, YP | 1 |
Vereshchagina, GV | 1 |
Kharchenko, VP | 1 |
Losev, SI | 1 |
Airoldi, M | 1 |
Gabriele, P | 1 |
Brossa, PC | 1 |
Pedani, F | 1 |
Tseroni, V | 1 |
D'Alberto, M | 1 |
Ragona, R | 1 |
Cheng, S | 1 |
Cheng, SY | 2 |
Hasumura, S | 2 |
Willingham, MC | 1 |
Pastan, I | 2 |
Kitagawa, S | 1 |
Obata, T | 1 |
Ronzoni, G | 1 |
Alquati, P | 1 |
Pola, P | 1 |
Alcini, E | 1 |
13 other studies available for triiodothyronine and Carcinoma, Epidermoid
Article | Year |
---|---|
Hypothyroidism after radiotherapy of head and neck cancer.
Topics: Aged; Carcinoma; Carcinoma, Squamous Cell; Dose Fractionation, Radiation; Female; Follow-Up Studies; | 2014 |
Treatment of myxedema coma after major thoracic surgery.
Topics: Carcinoma, Squamous Cell; Coma; Drug Therapy, Combination; Esophageal Neoplasms; Humans; Myxedema; P | 2011 |
[The state of hormonal homeostasis in patients with lung cancer under combined and radiation treatment].
Topics: Adenocarcinoma; Adrenocorticotropic Hormone; Adult; Carcinoma; Carcinoma, Squamous Cell; Combined Mo | 1984 |
Simultaneous detection of thyroglobulin (Tg), thyroxine (T4), and Triiodothyronine (T3) in nontoxic thyroid tumors by the immunoperoxidase method.
Topics: Adenocarcinoma; Adenoma; Carcinoma; Carcinoma, Papillary; Carcinoma, Squamous Cell; Cystadenoma; Hum | 1982 |
[Effects of estrogen and thyroid hormone on EGF receptor expression, proliferative activity and SCC production in the CaSki cervical carcinoma cells].
Topics: Antigens, Neoplasm; Carcinoma, Squamous Cell; Cell Division; ErbB Receptors; Estradiol; Female; Huma | 1995 |
Reduced non-oxidative glucose utilization in cancer patients is associated with a low triiodothyronine concentration.
Topics: Blood Glucose; Calorimetry, Indirect; Carcinoma, Squamous Cell; Female; Glucose; Glucose Clamp Techn | 1995 |
Pretreatment prevalence of hypothyroidism in patients with head and neck carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; H | 2001 |
[Endocrine system reaction in relation to the clinical manifestations of lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antigens; Carcinoma, Squamous Cell; Endocrine Glands; Female; Growth Ho | 1978 |
Serum thyroid hormone changes in head and neck cancer patients treated with microwave hyperthermia on lymph node metastasis.
Topics: Aged; Aged, 80 and over; Carcinoma; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Human | 1990 |
Structural similarities between the plasma membrane binding sites for L-thyroxine and 3,3',5-triiodo-L-thyronine in cultured cells.
Topics: Affinity Labels; Animals; Carcinoma, Squamous Cell; Cell Membrane; Cells, Cultured; Fibroblasts; Hum | 1985 |
Purification and characterization of a membrane-associated 3,3',5-triiodo-L-thyronine binding protein from a human carcinoma cell line.
Topics: Carcinoma, Squamous Cell; Carrier Proteins; Cell Line; Cholic Acids; Chromatography, Gel; Electropho | 1986 |
A cellular 3,3',5-triiodo-L-thyronine binding protein from a human carcinoma cell line. Purification and characterization.
Topics: Carcinoma, Squamous Cell; Cell Line; Cholic Acids; Detergents; Humans; Kinetics; Molecular Weight; R | 1987 |
[Study of prostatic carcinogenesis, using 20-methyl-cholanthrene in albino rats].
Topics: Adenocarcinoma; Adrenocorticotropic Hormone; Animals; Carcinoma, Squamous Cell; Hormones; Male; Meth | 1968 |